Early Freezing of Gait: Atypical versus Typical Parkinson Disorders

Parkinson's Disease
Abraham LiebermanMing-Jai Liu

Abstract

In 18 months, 850 patients were referred to Muhammad Ali Parkinson Center (MAPC). Among them, 810 patients had typical Parkinson disease (PD) and 212 had PD for ≤5 years. Among the 212 patients with early PD, 27 (12.7%) had freezing of gait (FOG). Forty of the 850 had atypical parkinsonism. Among these 40 patients, all of whom had symptoms for ≤5 years, 12 (30.0%) had FOG. FOG improved with levodopa in 21/27 patients with typical PD but did not improve in the 12 patients with atypical parkinsonism. FOG was associated with falls in both groups of patients. We believe that FOG unresponsive to levodopa in typical PD resembles FOG in atypical parkinsonism. We thus compared the 6 typical PD patients with FOG unresponsive to levodopa plus the 12 patients with atypical parkinsonism with the 21 patients with typical PD responsive to levodopa. We compared them by tests of locomotion and postural stability. Among the patients with FOG unresponsive to levodopa, postural stability was more impaired than locomotion. This finding leads us to believe that, in these patients, postural stability, not locomotion, is the principal problem underlying FOG.

References

Feb 1, 1992·Neurology·N GiladiS Fahn
Jul 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·A AchironE Melamed
Jan 29, 1999·Archives of Neurology·D J GelbS Gilman
Mar 23, 2001·Journal of Neural Transmission·N GiladiA D Korczyn
Jun 27, 2001·Neurology·N GiladiUNKNOWN Parkinson Study Group
Mar 26, 2002·Brain : a Journal of Neurology·Andrew J HughesAndrew J Lees
May 23, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·B H WoodR W Walker
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Jörg MüllerGregor K Wenning
Nov 16, 2002·Archives of Neurology·Stewart A FactorKenneth L Marek
Feb 8, 2003·Parkinsonism & Related Disorders·Tanya Gurevich, Nir Giladi
Jun 26, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J D SchaafsmaN Giladi
Jan 15, 2005·Brain : a Journal of Neurology·N M WarrenD J Burn
Apr 27, 2005·Annals of Neurology·Meir PlotnikJeffrey M Hausdorff
Sep 6, 2005·Clinical Neurology and Neurosurgery·Justin T DavisRajesh Pahwa
May 25, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Anna L BartelsKlaus L Leenders
Jun 20, 2006·Journal of the Neurological Sciences·Nir Giladi, Jeffrey M Hausdorff
Jun 27, 2006·Journal of the Neurological Sciences·Abraham Lieberman
Jul 19, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·W F AbdoB R Bloem
Oct 9, 2007·Brain Research Reviews·François Clarac
Apr 17, 2008·The European Journal of Neuroscience·Meir PlotnikJeffrey M Hausdorff
Nov 26, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzUNKNOWN Movement Disorder Society UPDRS Revision Task Force
May 13, 2009·Brain : a Journal of Neurology·Rachel CheeRobert Iansek
Sep 18, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·Q J Almeida, C A Lebold
Sep 24, 2009·Brain : a Journal of Neurology·M U FerrayeP Pollak
Aug 24, 2010·Neuroreport·Patrick M SchwederTipu Z Aziz
Mar 4, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Alfonso FasanoGünther Deuschl
Jul 23, 2011·Lancet Neurology·John G NuttAlice Nieuwboer
Sep 29, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Alberto J EspayDustin A Heldman
May 1, 2012·Parkinsonism & Related Disorders·T S VossUNKNOWN Falls Writing Group NINDS NET-PD Investigators
Oct 4, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Marianna AmboniGiuseppe Sorrentino
Oct 20, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Tal ShaharShimon Maimon
Oct 11, 2013·Frontiers in Systems Neuroscience·James M ShineSimon J G Lewis
Oct 24, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Talia HermanJeffrey M Hausdorff
Jan 11, 2014·Frontiers in Computational Neuroscience·Vignesh MuralidharanAhmed A Moustafa
Mar 7, 2014·PloS One·Daniel S PetersonGammon M Earhart

❮ Previous
Next ❯

Software Mentioned

MedCalc

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.